LENZ logo

LENZ Therapeutics, Inc. (LENZ) Cash From Financing

Annual CFF:

$199.00M+$118.30M(+146.59%)
December 31, 2024

Summary

  • As of today, LENZ annual cash from financing is $199.00 million, with the most recent change of +$118.30 million (+146.59%) on December 31, 2024.
  • During the last 3 years, LENZ annual cash from financing has fallen by -$218.47 million (-52.33%).
  • LENZ annual cash from financing is now -52.33% below its all-time high of $417.47 million, reached on December 1, 2021.

Performance

LENZ Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZcash flow metrics

Quarterly CFF:

$598.00K-$25.89M(-97.74%)
September 30, 2025

Summary

  • As of today, LENZ quarterly cash from financing is $598.00 thousand, with the most recent change of -$25.89 million (-97.74%) on September 30, 2025.
  • Over the past year, LENZ quarterly cash from financing has dropped by -$29.22 million (-97.99%).
  • LENZ quarterly cash from financing is now -99.73% below its all-time high of $219.50 million, reached on June 1, 2021.

Performance

LENZ Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZcash flow metrics

TTM CFF:

$27.18M-$29.22M(-51.81%)
September 30, 2025

Summary

  • As of today, LENZ TTM cash from financing is $27.18 million, with the most recent change of -$29.22 million (-51.81%) on September 30, 2025.
  • Over the past year, LENZ TTM cash from financing has dropped by -$724.00 thousand (-2.59%).
  • LENZ TTM cash from financing is now -93.71% below its all-time high of $432.27 million, reached on September 1, 2021.

Performance

LENZ TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LENZ Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+146.6%-98.0%-2.6%
3Y3 Years-52.3%+1113.6%+3981.5%
5Y5 Years+100.0%+1523.8%+81.8%

LENZ Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-52.3%>+9999.0%-99.3%+131.3%-67.4%+4515.1%
5Y5-Year-52.3%>+9999.0%-99.7%+131.3%-93.7%+4515.1%
All-TimeAll-Time-52.3%>+9999.0%-99.7%+131.3%-93.7%>+9999.0%

LENZ Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$598.00K(-97.7%)
$27.18M(-51.8%)
Jun 2025
-
$26.49M(>+9900.0%)
$56.40M(+88.5%)
Mar 2025
-
$44.00K(-17.0%)
$29.91M(+0.1%)
Dec 2024
$199.00M(+146.6%)
$53.00K(-99.8%)
$29.87M(+7.0%)
Sep 2024
-
$29.82M(+1660.3%)
$27.91M(-65.4%)
Dec 2023
$80.70M(>+9900.0%)
-$1.91M(-236.4%)
$80.70M(-2.6%)
Sep 2023
-
-$568.00K(-100.7%)
$82.86M(-0.6%)
Jun 2023
-
$83.19M(>+9900.0%)
$83.36M(>+9900.0%)
Mar 2023
-
-$8000.00(-103.3%)
$589.00K(-1.3%)
Dec 2022
$597.00K
-
-
Dec 2022
-
$244.00K(+513.6%)
$597.00K(-10.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$59.00K(-114.3%)
$666.00K(-98.0%)
Jun 2022
-
$412.00K(>+9900.0%)
$32.62M(-87.0%)
Mar 2022
-
$0.00(-100.0%)
$251.70M(-39.7%)
Dec 2021
$417.47M(+1288.0%)
$313.00K(-99.0%)
$417.47M(-3.4%)
Sep 2021
-
$31.89M(-85.5%)
$432.27M(+8.0%)
Jun 2021
-
$219.50M(+32.4%)
$400.34M(+104.4%)
Mar 2021
-
$165.77M(+996.3%)
$195.84M(+551.1%)
Dec 2020
$30.08M(>+9900.0%)
$15.12M(>+9900.0%)
$30.08M(+101.1%)
Sep 2020
-
-$42.00K(-100.3%)
$14.96M(-0.3%)
Jun 2020
-
$15.00M(>+9900.0%)
$15.00M(>+9900.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$0.00
-
-

FAQ

  • What is LENZ Therapeutics, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual cash from financing year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. quarterly cash from financing year-on-year change?
  • What is LENZ Therapeutics, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. TTM cash from financing year-on-year change?

What is LENZ Therapeutics, Inc. annual cash from financing?

The current annual cash from financing of LENZ is $199.00M

What is the all-time high annual cash from financing for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual cash from financing is $417.47M

What is LENZ Therapeutics, Inc. annual cash from financing year-on-year change?

Over the past year, LENZ annual cash from financing has changed by +$118.30M (+146.59%)

What is LENZ Therapeutics, Inc. quarterly cash from financing?

The current quarterly cash from financing of LENZ is $598.00K

What is the all-time high quarterly cash from financing for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly cash from financing is $219.50M

What is LENZ Therapeutics, Inc. quarterly cash from financing year-on-year change?

Over the past year, LENZ quarterly cash from financing has changed by -$29.22M (-97.99%)

What is LENZ Therapeutics, Inc. TTM cash from financing?

The current TTM cash from financing of LENZ is $27.18M

What is the all-time high TTM cash from financing for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high TTM cash from financing is $432.27M

What is LENZ Therapeutics, Inc. TTM cash from financing year-on-year change?

Over the past year, LENZ TTM cash from financing has changed by -$724.00K (-2.59%)
On this page